Last reviewed · How we verify
Diprivan
Diprivan, marketed by St. Antonius Hospital, is a general anesthetic with a well-established presence in the market. The drug's key composition patent is set to expire in 2028, providing a period of exclusivity that supports its competitive position. However, the lack of revenue data and key trial results poses a significant risk in assessing its long-term market sustainability.
At a glance
| Generic name | Diprivan |
|---|---|
| Also known as | Propofol |
| Sponsor | St. Antonius Hospital |
| Target | Cytochrome P450 2C9, Fatty-acid amide hydrolase 1, Transient receptor potential cation channel subfamily V member 4 |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- General anesthesia
- Sedation as Adjunct to Anesthesia
- Sedation in Intubated Patients
Common side effects
- Hypotension
- Apnea
- Tachycardia
- Bradycardia
- Cough
- Upper airway obstruction
- Hypoventilation
- Dyspnea
- Fever
- Pain
- Chest pain
- Arrhythmia
Serious adverse events
- Anaphylaxis/Anaphylactoid reaction
- Cardiac arrest
- Ventricular fibrillation
- Myocardial infarction
- Myocardial ischemia
- Atrioventricular heart block
- Atrial fibrillation
- Ventricular tachycardia
- Right heart failure
- Sepsis
Key clinical trials
- Total Intravenous and Balanced Anesthesia in Diabetic Patients Undergoing Video-Assisted Thoracoscopy (PHASE4)
- The Relationship Between Opioid-Free Anesthesia and Postoperative Agitation-Delirium and Quality of Recovery in Pediatric Ear, Nose, and Throat Cases Monitored With Perioperative Bispectral Index
- EEG and Pain Monitor Data Under Anesthesia to Study Pharmacodynamic Effects of Opioids and Sedatives (NA)
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- Effect of Remimazolam and Propofol on Postoperative Delirium (NA)
- Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery (NA)
- Propofol Versus Sevoflurane Anesthesia on the Intraocular Pressure and Hemodynamics in Patient Undergoing Cyclophotocoagulation (NA)
- Actualities in Procedural Sedation: Remimazolam (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diprivan CI brief — competitive landscape report
- Diprivan updates RSS · CI watch RSS
- St. Antonius Hospital portfolio CI